// Learn · Live Tracker

Is 7-OH Banned? Live Status Tracker

Last updated: July 17, 2026

This page tracks one question — is 7-OH banned, and when could that change? — with dates and docket numbers instead of countdown clocks. We update it whenever a federal filing, effective date, or state law moves. For the deeper history, see the full DEA timeline; for what an order would actually change on the ground, see what changes after August 5.

Is 7-OH banned? Status at a glance

Changelog: every dated development

What do the two DEA notices actually cover?

The DEA signed two notices of intent on July 1, 2026, both published in the Federal Register on July 6, 2026. They are separate actions with separate dockets, and the distinction matters when you read vendor claims about what is and isn't affected.

Notice 1 — 7-hydroxymitragynine (2026-13580, Docket DEA-1570)

This notice proposes temporary Schedule I placement for 7-hydroxymitragynine above a defined threshold: products containing 7-OH at more than 0.05% concentration or more than 1.00 mg per article (per tablet, capsule, gummy, or other unit). The threshold is the load-bearing detail. It means the notice targets concentrated and added 7-OH — the tablets, gummies, shots, and isolate powders built around the compound — while naturally occurring trace 7-OH below those levels in botanical kratom material stays outside Schedule I.

Notice 2 — related compounds (2026-13581, Docket DEA-1644)

The companion notice proposes temporary Schedule I placement for three compounds that have been marketed as 7-OH successors: mitragynine pseudoindoxyl ("pseudo"), MGM-15, and MGM-16. There is no threshold discussion to parse here — the compounds are named directly, and they ride the same 30-day clock as the 7-OH notice. Any product marketing these as "the legal alternative" is describing chemistry that is inside the federal action, not outside it. We break that category down in our legal alternatives guide.

What neither notice touches

Kratom leaf and mitragynine — the primary alkaloid in the leaf — are not scheduled by either notice. Plain leaf powder, crushed leaf, leaf capsules, and mitragynine-based extracts with no added or concentrated 7-OH remain outside both dockets. They stay governed by state kratom law, which is its own patchwork.

Which states have banned 7-OH?

Federal status is only half the map. As of July 2026: Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin prohibit 7-OH products. Tennessee and Kansas restrictions took effect July 1, 2026, ending vendor shipments to both states. Mississippi allows sales to adults 21+ except in 11 northeast counties. These state rules apply today and will keep applying whatever the DEA does on August 5. The state-by-state guide carries the full tier map.

When does the 7-OH ban take effect?

Two dates. July 31, 2026 closes the HHS comment window (Docket HHS-OASH-2026-0232) — the main open channel for public input, since temporary scheduling under 21 U.S.C. § 811(h) does not itself require comment. August 5, 2026 is the earliest either final order can take effect; a temporary order becomes effective the day it publishes in the Federal Register, with no additional grace period. Historically, temporary orders have often landed weeks or months after the earliest legal date — so the accurate framing is "August 5 at the earliest," not "banned on August 5."

How we update this page

We check the Federal Register and both DEA dockets (DEA-1570 and DEA-1644) for new documents, and we revise this page — and the "Last updated" stamp above — whenever a filing, final order, effective date, or state law changes the answer. If the stamp predates a development you know about, trust the primary documents at regulations.gov over this page and any vendor's marketing.

Frequently asked questions

Is 7-OH banned right now?

No. As of July 17, 2026, no federal scheduling order for 7-hydroxymitragynine is in effect. The DEA has published a notice of intent (Federal Register document 2026-13580, Docket DEA-1570), and the earliest a temporary Schedule I order could take effect is August 5, 2026. Several states ban or restrict 7-OH products independently of the federal action.

When does the 7-OH ban start?

The earliest possible date is August 5, 2026 — 30 days after the DEA notices published in the Federal Register on July 6, 2026. That is a floor, not a schedule: the DEA can issue a final order on that date, weeks or months later, or decline to act. A temporary order takes effect the day it publishes in the Federal Register.

Did the DEA ban kratom too?

No. Neither notice schedules kratom leaf or mitragynine, the primary kratom alkaloid. The 7-OH notice covers 7-hydroxymitragynine above 0.05% concentration or 1.00 mg per article; naturally occurring trace 7-OH below those thresholds in botanical kratom material stays outside Schedule I. State kratom laws still apply.

What are DEA-1570 and DEA-1644?

They are the two docket numbers for the DEA’s July 2026 notices of intent. DEA-1570 (Federal Register document 2026-13580) covers 7-hydroxymitragynine above 0.05% concentration or 1.00 mg per article. DEA-1644 (document 2026-13581) covers three related compounds: mitragynine pseudoindoxyl, MGM-15, and MGM-16. Both propose temporary placement in Schedule I on the same timeline.

Which states have already banned 7-OH?

As of July 17, 2026: Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin prohibit 7-OH products. Tennessee and Kansas restrictions took effect July 1, 2026, ending shipments to both states. Mississippi allows sales to adults 21+ except in 11 northeast counties. State laws apply regardless of what the DEA does federally.

Can I still comment on the federal 7-OH action?

The HHS request for information (Docket No. HHS-OASH-2026-0232) accepts public comments through July 31, 2026 at regulations.gov. Temporary scheduling under 21 U.S.C. 811(h) itself does not require a public comment period, which makes the HHS docket the main open channel.